Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
3.250
-0.010 (-0.31%)
May 13, 2026, 10:52 AM EDT - Market open
Lisata Therapeutics Employees
Lisata Therapeutics had 21 employees as of December 31, 2025. The number of employees decreased by 5 or -19.23% compared to the previous year.
Employees
21
Change (1Y)
-5
Growth (1Y)
-19.23%
Revenue / Employee
$8,095
Profits / Employee
-$778,619
Market Cap
29.35M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 21 | -5 | -19.23% |
| Dec 31, 2024 | 26 | 1 | 4.00% |
| Dec 31, 2023 | 25 | -2 | -7.41% |
| Dec 31, 2022 | 27 | 0 | - |
| Dec 31, 2021 | 27 | 3 | 12.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| IGC Pharma | 70 |
| Senti Biosciences Holdings | 39 |
| Kyntra Bio | 34 |
| Quantum BioPharma | 17 |
| BriaCell Therapeutics | 16 |
| Barinthus Biotherapeutics | 14 |
| Skye Bioscience | 12 |
| Neuphoria Therapeutics | 8 |
LSTA News
- 8 days ago - Halper Sadeh LLC is Investigating Whether SILA and LSTA are Obtaining Fair Deals for their Shareholders - GlobeNewsWire
- 2 months ago - Lisata Therapeutics to be acquired by Kuva Labs for $5 per share cash plus CVR - TheFly
- 2 months ago - Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc. - GlobeNewsWire
- 3 months ago - Lisata Therapeutics announces mutual termination of license agreement with Qilu - TheFly
- 3 months ago - Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide - GlobeNewsWire
- 4 months ago - Lisata Therapeutics downgraded to Hold from Buy at Brookline - TheFly
- 4 months ago - Lisata Therapeutics to be acquired by Kuva Labs for $4.00 per share - TheFly
- 4 months ago - Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer - GlobeNewsWire